Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 2
2005 1
2006 1
2007 2
2008 1
2011 2
2012 1
2013 1
2015 11
2016 8
2017 7
2018 11
2019 13
2020 16
2021 13
2022 8
2023 14
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

103 results

Results by year

Filters applied: . Clear all
Page 1
Secondary malignancies among mantle cell lymphoma patients.
Abalo KD, Smedby KE, Ekberg S, Eloranta S, Pahnke S, Albertsson-Lindblad A, Jerkeman M, Glimelius I. Abalo KD, et al. Among authors: glimelius i. Eur J Cancer. 2023 Dec;195:113403. doi: 10.1016/j.ejca.2023.113403. Epub 2023 Oct 29. Eur J Cancer. 2023. PMID: 37952281 Free article.
Novel treatment concepts in Hodgkin lymphoma.
Glimelius I, Diepstra A. Glimelius I, et al. J Intern Med. 2017 Mar;281(3):247-260. doi: 10.1111/joim.12582. Epub 2016 Dec 19. J Intern Med. 2017. PMID: 27991731 Free article. Review.
Comparative Analysis of the Humoral Immune Response to the EBV Proteome across EBV-Related Malignancies.
Argirion I, Pfeiffer RM, Proietti C, Coghill AE, Yu KJ, Middeldorp JM, Sarathkumara YD, Hsu WL, Chien YC, Lou PJ, Wang CP, Rothman N, Lan Q, Chen CJ, Mbulaiteye SM, Jarrett RF, Glimelius I, Smedby KE, Hjalgrim H, Hildesheim A, Doolan DL, Liu Z. Argirion I, et al. Among authors: glimelius i. Cancer Epidemiol Biomarkers Prev. 2023 May 1;32(5):687-696. doi: 10.1158/1055-9965.EPI-22-0452. Cancer Epidemiol Biomarkers Prev. 2023. PMID: 36788424 Free PMC article.
Checkpoint CD47 expression in classical Hodgkin lymphoma.
Gholiha AR, Hollander P, Löf L, Glimelius I, Hedstrom G, Molin D, Hjalgrim H, Smedby KE, Hashemi J, Amini RM, Enblad G. Gholiha AR, et al. Among authors: glimelius i. Br J Haematol. 2022 Jun;197(5):580-589. doi: 10.1111/bjh.18137. Epub 2022 Mar 17. Br J Haematol. 2022. PMID: 35301709 Free PMC article.
MRD-driven treatment with venetoclax-R2 in mantle cell lymphoma: the Nordic Lymphoma Group MCL7 VALERIA trial.
Jerkeman M, Kolstad A, Hutchings M, Pasanen A, Meriranta L, Niemann CU, Kragh Jørgensen RR, El-Galaly TC, Riise J, Leppä S, Christensen JH, Sonnevi K, Pedersen LB, Wader KF, Glimelius I. Jerkeman M, et al. Among authors: glimelius i. Blood Adv. 2024 Jan 23;8(2):407-415. doi: 10.1182/bloodadvances.2023011920. Blood Adv. 2024. PMID: 38113470 Free PMC article. Clinical Trial.
Reproduction patterns among classical Hodgkin lymphoma survivors treated with BEACOPP and ABVD in Sweden, Denmark and Norway-A population-based matched cohort study.
Entrop JP, Weibull CE, Smedby KE, Jakobsen LH, Øvlisen AK, Molin D, Glimelius I, Marklund A, Holte H, Fosså A, Smeland KB, El-Galaly TC, Eloranta S. Entrop JP, et al. Among authors: glimelius i. Int J Cancer. 2023 Aug 15;153(4):723-731. doi: 10.1002/ijc.34552. Epub 2023 Apr 29. Int J Cancer. 2023. PMID: 37119033
103 results